Contrasting effects of human, canine, and hybrid adenovirus vectors on the phenotypical and functional maturation of human dendritic cells: implications for clinical efficacy.
about
Host range, prevalence, and genetic diversity of adenoviruses in batsConditionally replicating adenovirus expressing TIMP2 increases survival in a mouse model of disseminated ovarian cancerCanine recombinant adenovirus vector induces an immunogenicity-related gene expression profile in skin-migrated CD11b⁺ -type DCs.Differentiated neuroprogenitor cells incubated with human or canine adenovirus, or lentiviral vectors have distinct transcriptome profiles.Canine adenovirus type 2 vector generation via I-Sce1-mediated intracellular genome release.A genetically engineered adenovirus vector targeted to CD40 mediates transduction of canine dendritic cells and promotes antigen-specific immune responses in vivoDNA/NYVAC vaccine regimen induces HIV-specific CD4 and CD8 T-cell responses in intestinal mucosa.Methods for gene transfer to the central nervous system.A Plasmodium Promiscuous T Cell Epitope Delivered within the Ad5 Hexon Protein Enhances the Protective Efficacy of a Protein Based Malaria VaccineThe number of Toll-like receptor 9-agonist motifs in the adenovirus genome correlates with induction of dendritic cell maturation by adenovirus immune complexesCorrective GUSB transfer to the canine mucopolysaccharidosis VII cornea using a helper-dependent canine adenovirus vector.Activation of a dendritic cell-T cell axis by Ad5 immune complexes creates an improved environment for replication of HIV in T cellsEmerging cancer vaccines: the promise of genetic vectors.Adenoviral virotherapy for malignant brain tumorsStrategies to overcome host immunity to adenovirus vectors in vaccine development.Engineered adenovirus serotypes for overcoming anti-vector immunity.Corrective GUSB transfer to the canine mucopolysaccharidosis VII brain.Patented cancer vaccines: the promising leads.New approaches to the development of adenoviral dendritic cell vaccines in melanoma.An update on canine adenovirus type 2 and its vectors.Central nervous system delivery of helper-dependent canine adenovirus corrects neuropathology and behavior in mucopolysaccharidosis type VII mice.Impact of adenovirus life cycle progression on the generation of canine helper-dependent vectors.Canine helper-dependent vectors production: implications of Cre activity and co-infection on adenovirus propagation.CD160-associated CD8 T-cell functional impairment is independent of PD-1 expression.Three-dimensional structure of canine adenovirus serotype 2 capsidImmunomodulatory and antitumor effects of type I interferons and their application in cancer therapy.Regulation of antigen presentation machinery in human dendritic cells by recombinant adenovirus.Shutdown of immunological priming and presentation after in vivo administration of adenovirus.Humoral immune response to adenovirus induce tolerogenic bystander dendritic cells that promote generation of regulatory T cells
P2860
Q33769343-E944038E-523F-481D-9D94-C882E1048B3BQ34055529-3F14F452-B71C-4A3A-A7FB-5C36147BEC9CQ34540809-6A178F67-508E-4C1B-8161-E3A3F78C3149Q34904038-A24EBA9D-C049-4780-88D2-EC4EB8D4F3FCQ34926393-E551D1F0-44C5-4EFA-86F2-12DD168E0D51Q35005484-3C3D8A98-006C-4DAD-934C-284759552F7FQ35382338-EB57A3BF-22FF-4323-80F6-6688891ED256Q35902332-5EBA31CF-95C4-4BF3-A7CE-0E1AD4AB0209Q36003208-A9535FBF-622A-4D6A-BADF-84BEE7D523DDQ36023055-D5622C59-463B-48A9-BB39-848E1F8B0E12Q36219639-EC219D15-91E0-46DF-B09B-7849914D225CQ36979919-C5D7BC7C-5A99-4B5C-B65E-47799470AC9BQ37137464-E41E6745-D6FA-4007-8785-3C1AD2040D82Q37223846-51AD472F-3157-4FBF-88E0-8843DD16F47DQ37503253-CB23F84C-BB7E-4E17-8871-B24189E482F9Q37567831-E3B1950E-7AEF-4EE1-A6CA-895B35970AF8Q37698448-8E5172C1-AE40-4B52-B8EF-2C5E747B24E9Q37719552-481532DA-EAC8-450C-B49B-7BA83893EF29Q37820489-607219D4-4351-4EC0-8CEF-96143104A746Q37945220-971BAA33-0F14-401E-A17D-C1E13106F2D7Q38287249-ECE5AABE-DB08-40BB-8EB1-9EF6C0ECBFA2Q38945731-DA58238B-A337-4E1A-90EF-5B2173BC56B5Q41429339-3002E638-A009-4D6F-9225-CFE7BC6F8EF0Q41726535-239BF5B9-FB25-42F3-9732-62E855BB8653Q41995616-AFF7CA1F-0613-4BB1-AA79-6E496CBAFBADQ42378527-3C44DDC4-C2DB-4FD4-928B-8E104F6E63A4Q43069927-8D8B465F-C022-45BD-A0AD-16142ED7893DQ45875060-8F348822-D9FE-47B6-8DBE-3F7F6E7D5AFAQ58734410-5C7AA0E9-D279-4E76-AA09-3E399518EE64
P2860
Contrasting effects of human, canine, and hybrid adenovirus vectors on the phenotypical and functional maturation of human dendritic cells: implications for clinical efficacy.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Contrasting effects of human, ...... cations for clinical efficacy.
@en
type
label
Contrasting effects of human, ...... cations for clinical efficacy.
@en
prefLabel
Contrasting effects of human, ...... cations for clinical efficacy.
@en
P2093
P2860
P356
P1433
P1476
Contrasting effects of human, ...... cations for clinical efficacy.
@en
P2093
Eric J Kremer
Franck Mennechet
Joel N Glasgow
Matthieu Perreau
Nicolas Serratrice
P2860
P304
P356
10.1128/JVI.01530-06
P407
P577
2007-01-17T00:00:00Z